Page last updated: 2024-09-05

tak 779 and peptide t1249

tak 779 has been researched along with peptide t1249 in 1 studies

Compound Research Comparison

Studies (tak 779)	Trials (tak 779)	Recent Studies (post-2010) (tak 779)	Studies (peptide t1249)	Trials (peptide t1249)	Recent Studies (post-2010) (peptide t1249)
118	1	35	28	2	5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antunes, F; Barroso, H; Bártolo, I; Borrego, P; Caixas, U; Calado, R; Cavaco-Silva, P; Doroana, M; Maltez, F; Marcelino, JM; Rocha, C; Taveira, N	1

Other Studies

1 other study(ies) available for tak 779 and peptide t1249

Article	Year
Baseline susceptibility of primary HIV-2 to entry inhibitors. Antiviral therapy, 2012, Volume: 17, Issue:3 Topics: Amides; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Male; Maraviroc; Microbial Sensitivity Tests; Peptide Fragments; Quaternary Ammonium Compounds; Triazoles	2012

Article

Year

Baseline susceptibility of primary HIV-2 to entry inhibitors.

Antiviral therapy, 2012, Volume: 17, Issue:3

Topics: Amides; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Male; Maraviroc; Microbial Sensitivity Tests; Peptide Fragments; Quaternary Ammonium Compounds; Triazoles

2012